Status | Study |
Recruiting |
Study Name: Down Syndrome Metabolic Health Study Condition: Down Syndrome Trisomy 21 Date: 2013-03-27 |
Active, not recruiting |
Study Name: Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells Condition: Trisomy 21 Date: 2012-11-08 Interventions: Other: sample blood Other Names: Non Invasive Prenatal Diagnos |
Recruiting |
Study Name: Trisomy 21 in Adulthood Condition: Down Syndrome Date: 2012-08-08 Interventions: Genetic: karyotype |
Completed |
Study Name: Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies Condition: Aneuploidy Down Syndrome Noninvasive Prenatal Screening Date: 2012-05-09 Interventions: Device: SEQureDx Trisomy Test Plasma samples obtained from maternal blood will be tested using the SEQur |
Completed |
Study Name: Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome Condition: Myelodysplastic Syndrome MDS Trisomy Date: 2012-04-23 Interventions: Drug: rigosertib Rigosertib sodium will be available as so |
Completed |
Study Name: Non-invasive Chromosomal Examination of Trisomy Study Condition: Trisomy 21 Date: 2012-01-13 |
Terminated |
Study Name: Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21 Condition: Pregnancy Date: 2011-01-31 |
Completed |
Study Name: Prenatal Test for Fetal Aneuploidy Detection Condition: Aneuploidy Trisomy 21 Date: 2010-11-22 |
Completed |
Study Name: Trisomy of Chromosome 21 Diagnosis by High Output Sequencing Condition: Trisomy 21 - Translocation Date: 2010-04-28 |
Completed |
Study Name: Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk Condition: Myelodysplastic Syndromes Date: 2009-09-24 |